SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-16-163613
Filing Date
2016-12-23
Accepted
2016-12-23 08:11:52
Documents
3
Period of Report
2016-12-23

Document Format Files

Seq Description Document Type Size
1 6-K a16-23641_16k.htm 6-K 16801
2 EX-99.1 a16-23641_1ex99d1.htm EX-99.1 19392
3 GRAPHIC g236411mmi001.jpg GRAPHIC 3348
  Complete submission text file 0001104659-16-163613.txt   42012
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 162067941
SIC: 2834 Pharmaceutical Preparations